However, this is considered unlikely to play an important role, since identical TP53 mutations and homogeneous loss of heterozygosity of the TP53 locus were detected across separated tumor regions in EAC previously [45], and a homogenous IHC was identified in all cases. The gene discussed is TP53; the disease is neoplasm.